Navigation Links
Photonic Products Group, Inc. ("PPGI") Releases FY 2010 Financial Results
Date:4/4/2011

3,3452,588,481Precious Metals157,443157,443Deferred Income Taxes408,000408,000Goodwill311,572311,572Intangible Assets, net of accumulated amortization 594,452673,016Other Assets47,23545,192Total Assets$

12,621,803$

12,610,740Liabilities and Shareholders' EquityCurrent Liabilities:Current portion of notes payable -other$

9,000$

9,000Accounts payable and accrued liabilities836,190657,650Customer advances441,987346,429Total Current Liabilities1,287,1771,013,079Related Party Convertible Notes Payable2,500,0002,500,000Accrued Interest on Related Party Convertible Note Payable1,125,000975,000Notes Payable – Other, net of current portion335,874344,946Total Liabilities5,248,0514,833,025Commitments Shareholders' equity:Common stock: $.01 par value; 60,000,000 authorized shares 11,562,656 issued at December 31, 2010 and 11,443,347 issued at December 31, 2009115,626114,433Capital in excess of par value17,402,52817,073,871Accumulated deficit(10,129,452)(9,395,639)7,388,7027,792,665Less - Common stock in treasury, at cost (4,600 shares)(14,950)(14,950)Total Shareholders' Equity7,373,7527,777,715Total Liabilities and Shareholders' Equity$

12,621,803$

12,610,740PHOTONIC PRODUCTS GROUP, INC AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF OPERATIONSYears Ended December 31,201020092008RevenuesNet sales$

11,054,178$

11,051,127$

16,301,209Cost and expensesCost of goods sold8,545,1538,896,53911,486,620Selling, general and administrative expense3,105,0633,278,1613,857,805Goodwill Impairment—1,558,074—11,650,21613,732,77415,344,425Operating (loss) income(596,038)(2,681,647)956,784Other income (expense)Interest expense, net(137,775)(130,387)(170,476)Gain on sale of plant and equipment—4,6719,113Gain on sale of precious metals—7,371—(137,775)(118,345)(161,363)(Loss) income before income taxes (733,813)(2,799,992)795,421Income tax benefit (provision) ——303,000Net (loss) income $

(
'/>"/>

SOURCE Photonic Products Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. OTC Anti-Aging Products: Hype or Hope?
2. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
3. Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products
4. Rcadias COR Analyzer Family of Products Receives Second FDA Clearance
5. Cantel Medical Corp.s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products
6. Positive Results Published Using AtriCure Minimally Invasive Products
7. IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival
8. Data Demonstrate that Obagi Medical Products Condition & Enhance Skin Care System is an Effective Complement to Facial Rejuvenation Procedures
9. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
10. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
11. TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015  Soligenix, Inc. ... biopharmaceutical company developing products that address unmet medical ... biodefense, announced today it has received a positive ... continue enrolling into the company,s Phase 2 study ... as a treatment for oral mucositis in patients ...
(Date:3/2/2015)... , March 2, 2015 Amgen (NASDAQ: ... 15 abstracts, including data evaluating Repatha TM (evolocumab), ... an investigational drug for chronic heart failure, at the ... Scientific Session (ACC.15), being held March 14-16 in ... a fully human monoclonal antibody that inhibits proprotein convertase ...
(Date:3/2/2015)...  Compass Diversified Holdings (NYSE: CODI ) ... leading middle market businesses, announced today its consolidated operating ... 31, 2014. Fourth Quarter 2014 Highlights ... ("CAD" or "Cash Flow") of $17.5 million for the ... full year 2014;  , Reported net income of ...
Breaking Medicine Technology:Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 2Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 3Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 4Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 5Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 6Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 7Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 8Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 9Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 10Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 11Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 2Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 3Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 4Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 5Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 6Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 7Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 8Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 9Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 10Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 11Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 12Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 13Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 14Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 15
... SILVER SPRING, Md., Nov. 30, 2011 The U.S. ... version of the cholesterol-lowering drug Lipitor (atorvastatin calcium tablets). ... Ranbaxy Laboratories Ltd. has gained approval to make generic ... mg, and 80 mg strengths. The drug will be ...
... PRINCETON, N.J., Nov. 30, 2011 IntegriChain, Inc., a ... by Forbes as #19 on the list of America,s ... services to help customers improve order forecasting, order monitoring, ... planning. IntegriChain has grown 60% over the past three ...
Cached Medicine Technology:FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor 2FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor 3Forbes Announces IntegriChain in Top 20 on List of America's Most Promising Companies 2
(Date:3/3/2015)... Angeles, CA (PRWEB) March 03, 2015 ... Boost , a fast weight loss product that is ... country. This is because it contains ingredients that help ... Boost is a new combination diet product thought to ... Metabolism Boost contains three ingredients, all directed at ...
(Date:3/3/2015)... Dallas, TX (PRWEB) March 03, 2015 ... Janie Schumaker, RN, BSN, MBA, CEN, CPHQ, FABC as ... commitment to clinically-focused innovation for unscheduled, episodic care. ... to care, making episodic care settings including urgent care ... market segments in healthcare,” said Roger Davis, T-System’s chief ...
(Date:3/3/2015)... The Forbes Living producers are ... when planning an Eco-vacation. It will review the basics ... The segment will explore the greenest ground transportation options, ... policy, request Earth-friendly choices along the way, and much ... to save electricity while away. More people are searching ...
(Date:3/3/2015)... 2015 The Data 360 Conference ... Ford Conference Center, Dearborn, MI, on March 5, 2015. ... a featured speaker. He is known internationally as “The Father ... These designations were earned due to years of R&D on ... DB, released over 10 years ago. Subsequent developments in Big ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 First ... freestanding emergency rooms in the United States, named Jeffrey ... its Louetta facility. , “We are pleased to ... of our Louetta facility,” said Dr. James M. Muzzarelli, ... , Dr. Smaistrla received his undergraduate and medical degrees ...
Breaking Medicine News(10 mins):Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 2Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 3Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 4Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 2Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 3Health News:Forbes Living Segment on Planning an Eco-Vacation in the Works 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 4Health News:First Choice Emergency Room Announces Dr. Jeffrey Smaistrla as New Medical Director of LouettaFacility 2
... is often referred to as the fifth vital sign. ... other critical care settings cannot be doubted. Pulse oximetry ... of years and recent advances have made the process ... accurate. However, the pulse oximetry market faces the same ...
... With ... but in a recent literature study published in the July/August issue of Sports Health: ... disease. , ... (Vocus) June 24, 2009 -- With skin cancer rates on the increase, most individuals know ...
... ... on clinical nutrition and preventive medicine, is now a featured expert on searchjointpain.com, a new ... , ... 2009 -- Susan Lark, MD, an eminent authority on clinical nutrition and preventive medicine, is ...
... ... an optimal nutritional supplement to support overall health and laminitis prevention for at-risk horses. ... Shenandoah, IA (PRWEB) June 24, ... of these horses are insulin resistant, and as such are at a higher risk for ...
... , ... Survey confirms that online scheduling converts Internet surfers into new customers, provides customer ... ... 2009 -- Appointment-Plus ( www.appointment-plus.com ), the industry leader in web-based scheduling software, ...
... ... could barely keep up with demand to sample and learn about their new products at ... entire day. , ... TX (PRWEB) June 24, 2009 -- Bariatric Advantage, a Division of Catalina Lifesciences, could barely ...
Cached Medicine News:Health News:Pulse Oximetry Entrenched as Standard-of-Care in Patient Monitoring, States Frost & Sullivan 2Health News:Pulse Oximetry Entrenched as Standard-of-Care in Patient Monitoring, States Frost & Sullivan 3Health News:Pulse Oximetry Entrenched as Standard-of-Care in Patient Monitoring, States Frost & Sullivan 4Health News:Study Finds Skin Cancer Rates Higher Among Athletes 2Health News:Women's Health Expert Dr. Susan Lark Featured on Searchjointpain.com 2Health News:Equine Obesity is Associated with Significant Health Issues, Including Insulin Resistance and Laminitis 2Health News:Web-based Scheduling Software is the New Online Shopping Cart for Services 2Health News:Web-based Scheduling Software is the New Online Shopping Cart for Services 3Health News:Interest in the Bariatric Advantage Chewy Bites and Other New Products is at an All-Time High at the ASMBS Conference 2
... POLYGRAM NET™ (PNET) works with the ... analyze pressure and EMG signals from ... graphic format. The PNET software and ... or water-perfused manometry catheters as well ...
... BloodSTOP hemostatic gauze is a revolutionary hypoallergenic ... from biologically inert natural regenerated cellulose. Whether ... safely and quickly stops bleeding. When BloodSTOP ... with blood platelets and fibrin to form ...
Capillaries available in glass and "non-PVC" plastic. Match different analyzer requirements. Variety of sizes match sample-volume requirements of individual analyzers....
... high-efficiency network for your cardiology department designed ... expandable platform., If your requirements are to:, ... images in real-time (25/30 f/s), Distribute result ... of speed, Connect several cardiac cath labs ...
Medicine Products: